GB0021421D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0021421D0
GB0021421D0 GBGB0021421.3A GB0021421A GB0021421D0 GB 0021421 D0 GB0021421 D0 GB 0021421D0 GB 0021421 A GB0021421 A GB 0021421A GB 0021421 D0 GB0021421 D0 GB 0021421D0
Authority
GB
United Kingdom
Prior art keywords
sub
hydrogen
specific substituents
compounds
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0021421.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Glycosciences UK Ltd
Original Assignee
Oxford Glycosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Glycosciences UK Ltd filed Critical Oxford Glycosciences UK Ltd
Priority to GBGB0021421.3A priority Critical patent/GB0021421D0/en
Publication of GB0021421D0 publication Critical patent/GB0021421D0/en
Priority to JP2002522888A priority patent/JP2004507501A/ja
Priority to ES01963157T priority patent/ES2282283T3/es
Priority to EP01963157A priority patent/EP1313471B1/en
Priority to AT01963157T priority patent/ATE359073T1/de
Priority to PCT/GB2001/003862 priority patent/WO2002017915A1/en
Priority to AU2001284190A priority patent/AU2001284190A1/en
Priority to DE60127845T priority patent/DE60127845T2/de
Priority to US10/371,964 priority patent/US7105554B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
GBGB0021421.3A 2000-08-31 2000-08-31 Compounds Ceased GB0021421D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB0021421.3A GB0021421D0 (en) 2000-08-31 2000-08-31 Compounds
JP2002522888A JP2004507501A (ja) 2000-08-31 2001-08-30 ベンジリデンチアゾリジンジオンおよび抗真菌剤としてのそれらの使用
ES01963157T ES2282283T3 (es) 2000-08-31 2001-08-30 Derivados de bencilideno tiazolidinadionas y su uso como agentes antifungicos.
EP01963157A EP1313471B1 (en) 2000-08-31 2001-08-30 Benzylidene thiazolidinediones and their use as antimycotic agents
AT01963157T ATE359073T1 (de) 2000-08-31 2001-08-30 Benzylidenthiazolidindione und ihre verwendung als antimykotische mittel
PCT/GB2001/003862 WO2002017915A1 (en) 2000-08-31 2001-08-30 Benzylidene thiazolidinediones and their use as antimycotic agents
AU2001284190A AU2001284190A1 (en) 2000-08-31 2001-08-30 Benzylidene thiazolidinediones and their use as antimycotic agents
DE60127845T DE60127845T2 (de) 2000-08-31 2001-08-30 Benzylidenthiazolidindione und ihre verwendung als antimykotische mittel
US10/371,964 US7105554B2 (en) 2000-08-31 2003-02-21 Benzylidene thiazolidinediones and their use as antimycotic agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0021421.3A GB0021421D0 (en) 2000-08-31 2000-08-31 Compounds

Publications (1)

Publication Number Publication Date
GB0021421D0 true GB0021421D0 (en) 2000-10-18

Family

ID=9898616

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0021421.3A Ceased GB0021421D0 (en) 2000-08-31 2000-08-31 Compounds

Country Status (9)

Country Link
US (1) US7105554B2 (enExample)
EP (1) EP1313471B1 (enExample)
JP (1) JP2004507501A (enExample)
AT (1) ATE359073T1 (enExample)
AU (1) AU2001284190A1 (enExample)
DE (1) DE60127845T2 (enExample)
ES (1) ES2282283T3 (enExample)
GB (1) GB0021421D0 (enExample)
WO (1) WO2002017915A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0204252D0 (en) * 2002-02-23 2002-04-10 Oxford Glycosciences Uk Ltd Novel compounds
WO2003070238A1 (en) * 2002-02-23 2003-08-28 Oxford Glycosciences (Uk) Ltd Thiazolidine antifungal agents
WO2005092840A1 (en) 2004-03-23 2005-10-06 Pfizer Limited Formamide derivatives useful as adrenoceptor
CA2628725A1 (en) 2005-11-15 2007-05-31 Glycofi, Inc. Production of glycoproteins with reduced o-glycosylation
WO2007079466A2 (en) * 2006-01-04 2007-07-12 Nano Mist International, Llc Air driven delivery system for sprayable media
US8637435B2 (en) * 2007-11-16 2014-01-28 Merck Sharp & Dohme Corp. Eukaryotic cell display systems
JP5731827B2 (ja) * 2008-03-03 2015-06-10 グライコフィ， インコーポレイテッド 下等真核生物中での組換えタンパク質の表面ディスプレイ
AU2009249314A1 (en) 2008-05-20 2009-11-26 Merck Sharp & Dohme Corp. Efficient production of heterologous proteins using mannosyl transferase inhibitors
US8067339B2 (en) 2008-07-09 2011-11-29 Merck Sharp & Dohme Corp. Surface display of whole antibodies in eukaryotes
EP2324121B1 (en) 2008-08-12 2012-11-07 GlycoFi, Inc. Improved vectors and yeast strains for protein production: ca2+ atpase overexpression
EP2678440B1 (en) 2011-02-25 2018-05-23 Merck Sharp & Dohme Corp. Yeast strain for the production of proteins with modified o-glycosylation
WO2013018735A1 (ja) 2011-07-29 2013-02-07 大正製薬株式会社 アミジン化合物又はその塩
WO2014024897A1 (ja) * 2012-08-06 2014-02-13 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 チアゾリジンジオンおよびピロリジンジオン誘導体、並びにそれらを有効成分としてなる殺菌剤
WO2014062811A2 (en) * 2012-10-16 2014-04-24 New York University METHOD OF TREATING CANCER WITH MODULATORS OF SCFSkp2
MX364532B (es) 2013-07-04 2019-04-29 Glykos Finland Oy Celulas de hongos filamentosos deficientes de o-manosiltransferasa y metodos de uso de las mismas.
SG11201700446XA (en) 2014-07-21 2017-02-27 Glykos Finland Oy Production of glycoproteins with mammalian-like n-glycans in filamentous fungi
EP3468555B1 (en) * 2016-06-14 2023-08-09 Versitech Limited Compositions for use in treating bacterial infections
CN109476656A (zh) * 2016-06-24 2019-03-15 俄亥俄州大学 葡萄糖转运抑制剂及使用其的方法
RU2662153C1 (ru) * 2017-04-20 2018-07-24 Общество С Ограниченной Ответственностью "Дермавитал Групп" Гибридные эфиры на основе производных тиазолидин-2,4-диона и азолов (1н-1,3-имидазола и 1н-1,3,4-триазола) и их применение
RU2690161C1 (ru) * 2018-06-28 2019-05-31 Общество С Ограниченной Ответственностью "Дермавитал Групп" 3,5-Замещенные производные тиазолидин-2,4-диона, обладающие противомикробной активностью
RU2703997C1 (ru) * 2018-12-13 2019-10-23 Общество с ограниченной ответственностью "Л-Био" Гибридные амиды на основе триазола и тиазолидина, обладающие антимикробной активностью
CN112521382A (zh) * 2020-12-14 2021-03-19 西南大学 芦荟大黄素噻唑烷二酮类化合物及其制备方法和应用
WO2024258316A1 (ru) * 2023-06-16 2024-12-19 Общество с ограниченной ответственностью "Л-Био" Новые потенциальные противогрибковые средства на основе тиазолидин-2,4-диона и триазола

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6156175A (ja) * 1984-08-24 1986-03-20 Yamanouchi Pharmaceut Co Ltd ロダニン誘導体およびその製造法
IL106877A (en) * 1992-09-10 1998-03-10 Lilly Co Eli Rhodanine derivatives for use as medicaments for the treatment of alzheimer's disease
DE4318550A1 (de) * 1993-06-04 1994-12-08 Boehringer Mannheim Gmbh Aryliden-4-oxo-2-thioxo-3- thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
JPH08109175A (ja) * 1994-10-07 1996-04-30 Torii Yakuhin Kk チアゾリジン−２−オンエステル誘導体
JPH08109174A (ja) * 1994-10-07 1996-04-30 Torii Yakuhin Kk チアゾリジン−２−オン誘導体
EP1117655A1 (en) * 1998-09-30 2001-07-25 Angelika Esswein Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
WO2000018746A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
US6506755B2 (en) * 2000-02-03 2003-01-14 Hoffmann-La Roche Inc. Thiazolidinecarboxyl acids

Also Published As

Publication number Publication date
DE60127845D1 (de) 2007-05-24
US20040006112A1 (en) 2004-01-08
JP2004507501A (ja) 2004-03-11
ES2282283T3 (es) 2007-10-16
EP1313471B1 (en) 2007-04-11
ATE359073T1 (de) 2007-05-15
EP1313471A1 (en) 2003-05-28
WO2002017915A1 (en) 2002-03-07
AU2001284190A1 (en) 2002-03-13
US7105554B2 (en) 2006-09-12
DE60127845T2 (de) 2007-12-20

Similar Documents

Publication Publication Date Title
GB0021421D0 (en) Compounds
IS4425A (is) Arylþíósambönd sem varnarefni gegn bakteríum og veirum
IL157773A0 (en) 2-amino-propanol derivatives
MY125359A (en) Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods.
EP0669324A4 (en) CHINAZOLIN DERIVATIVES.
DE60214591D1 (en) Pyrazolpyrimidinfungizide
MXPA05010652A (es) Pirazoles sustituidos.
TW200510405A (en) Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
MXPA05007754A (es) Inhibidores de polimerasa viral.
GEP20074198B (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials
IS6309A (is) Kínasólínafleiður
MY134701A (en) Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
SE0004245D0 (sv) Novel compounds and their use
WO2004048340A8 (en) Sinomenine and sinomenine compounds, synthesis and use
GEP20043172B (en) Combination Chemotherapy
WO2003035620A1 (en) Bicyclic compound
ATE172463T1 (de) Pyrrolocarbazol
CA2309474A1 (en) New 4-arylpiperidine derivatives for the treatment of pruritus
SI1377574T1 (enExample)
CA2206125A1 (en) N-substituted hydrazinophenylsulphonylureas, as herbicides and plant growth regulators
SE0003186D0 (sv) New process
EP1203763A3 (de) Beta-Hydroxyalkylamide, Verfahren zu ihrer Herstellung und deren Verwendung
CY1107515T1 (el) Συνθεση ενδιαμεσων χρησιμων στην παρασκευη τρικυκλικων ενωσεων
GB0412893D0 (en) Novel antiviral macrocycle derivatives and metal complexes, incorporating bridged macrocycles
TWI256383B (en) Anthraquinone compound

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)